Bioengineering
Point Therapeutics Reports Second Quarter 2007 Financial Results
Published in Lab Law Weekly, August 24th, 2007
Point reported a net loss of $3,282,000, or $0.08 per basic and diluted share, in the second quarter of 2007, compared with a net loss of $7,346,000, or $0.22 per basic and diluted share, in the second quarter of 2006. Point reported a net loss of $8,561,000, or $0.23 per basic and diluted share, in the first six months of 2007, compared with a net loss of $15,203,000, or $0.46 per basic and diluted share, for the first six months of 2006.
Point's cash and restricted cash balance as of June 30, 2007 was $3,917,000.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2007-08-24)
More Articles from Lab Law Weekly
- Aarp
Seniors Set to be Hit Hard by Illinois Budget - Americans United for Life
Kansas Abortionist Tiller's Claims Without Merit Americans United for Life Amicus Brief Says - BG Medicine, Inc.
BG Medicine Files US Registration Statement with SEC in Support of Euronext Amsterdam IPO - Bioengineering
AutoImmune Inc. Reports 2007 Second Quarter Financial Results - Biomedicine
Spectral reports second quarter results - Biopharmaceuticals
GTC Biotherapeutics Reports Second Quarter 2007 Financial Results - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
